We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
IDT Opens Molecular Biology R&D Facility in Redwood City
News

IDT Opens Molecular Biology R&D Facility in Redwood City

IDT Opens Molecular Biology R&D Facility in Redwood City
News

IDT Opens Molecular Biology R&D Facility in Redwood City

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "IDT Opens Molecular Biology R&D Facility in Redwood City"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Already the world’s leader in custom nucleic acid synthesis, Integrated DNA Technologies (IDT) is capitalizing on its expertise to deliver a broader range of validated molecular biology products. Research and development for these products will now be performed in a newly built facility in Redwood City, California. The 8,000 square foot building houses state-of-the-art labs that will allow IDT scientists to maximize the company’s world-class custom oligonucleotide manufacturing capability. For an advance look, view a video of IDT’s new Redwood City R&D facility. 

This new Center of Excellence for research and development keeps IDT on the cutting edge of innovation in molecular biology applications, particularly qPCR, next generation sequencing (NGS), and synthetic biology (SynBio). “For years we’ve focused on enabling research,” said Stephen Gunstream, Chief Commercial Officer. “Redwood City takes that mission to the next level. Now, in addition to our traditional offerings, we will be able to develop complete workflow solutions for cutting edge applications. This provides more value to our customers.”

To lead Redwood City’s Product Development Team, IDT is pleased to announce that Dr Caifu Chen has joined the company as Senior Vice President for Research and Development. Dr Chen has 25 years of genomics research experience in the academic and biotech sectors, particularly in developing qPCR- and NGS-based assay products for research and diagnostics applications.

“I’m very excited to join the Redwood City team,” said Dr Chen. “We built this new facility for two reasons: One, to have a presence in the Bay Area, which is the worldwide center of the biotech industry. Second, we want to attract top talent that will develop innovative, robust solutions for NGS and qPCR. Robust products equal happier customers. This is our goal.” 

“The addition of Dr Chen to our R&D team ensures that our customers can continue to rely on IDT to deliver impactful, high quality products in a timely manner,” said Dr Joseph A. Walder, founder and CEO of IDT. “Dr Chen will build and manage our team of R&D experts who will develop breakthrough genomic solutions.”

To celebrate the opening of its Redwood City Center of Excellence in R&D, IDT will host a special event on April 30, 2015, beginning at noon.  The event will include facility tours, networking, and presentations by IDT executives.  

Advertisement